Corvus Pharmaceuticals discusses 2024 earnings and future risks

Corvus Pharmaceuticals held its earnings call for the fourth quarter and full year of 2024 on March 25, 2025. The event featured key executives, including CEO Richard Miller and CFO Leiv Lea. During the call, they shared updates on the company’s business and financial performance. Listeners included investment analysts from various firms. The speakers warned that some comments would include forward-looking statements. These predictions are based on current estimates but could change due to various risks and uncertainties. A report detailing these risks was filed by Corvus with the SEC. The company is not obligated to update any forward-looking statements unless required by law.